About John T. DellaCroce, M.D.
Eye Care Specialist

Retina Center of Arkansas
John T. DellaCroce, M.D.

1794 E Joyce Blvd. Suite 3
Fayetteville, AR 72703 MAP
Phone: (479) 234-4499
Fax: (479) 269-1325

Dr. John DellaCroce is a board-certified ophthalmologist and fellowship-trained vitreoretinal microsurgeon who specializes in the treatment of diseases involving the retina, vitreous, and macula. He provides state-of-the-art, high-quality eye care to patients in Northwest Arkansas.

Dr. DellaCroce is highly skilled in the latest surgical techniques for a wide range of eye health issues including retinal detachments, epiretinal membranes (macular pucker), macular holes, retinal tears, diabetic tractional retinal detachments, as well as the treatment of age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions, and many other diseases of the retina and vitreous.

EDUCATION

Undergraduate:

1997 
Bachelor of Science Biomedical Engineering, magna cum laude
Louisiana Tech University

Graduate:

2002
Doctor of Medicine
Louisiana State University Health Sciences Center

POSTGRADUATE TRAINING

Internship 2002-2003:

Internal Medicine
Louisiana State University Health Sciences Center
Veterans Administration Hospital

Residency 2003-2006:

Ophthalmology
Tulane University Health Sciences Center
Charity Hospital of New Orleans
Huey P. Long Medical Center
Veterans Administration Hospital, Alexandria, Louisiana
Veterans Administration Hospital, Biloxi, Mississippi
Veterans Administration Hospital, New Orleans, Louisiana

Fellowship 2006-2008:

Vitreoretinal Surgery, Medical Retina and Posterior Uveitis
University of Utah – John A. Moran Eye Center
Veterans Administration Hospital, Salt Lake City, Utah
Primary Children’s Hospital- Salt Lake City, Utah

ACADEMIC APPOINTMENTS/PRIOR POSITIONS

Assistant Professor of Ophthalmology 2008-2011:
Tulane University Health Sciences Center
Medical Center of Louisiana – New Orleans
Veterans Administration Hospital, Alexandria, Louisiana
Vitreoretinal Surgeon/Retina Specialist 2009 – 2011
Eyecare Associates of New Orleans

CERTIFICATION:

Diplomate National Board of Medical Examiners 2003
Diplomate American Board of Ophthalmology 2008
Arkansas State Medical Board 2011- present
Louisiana State Medical Board 2003-2012
Utah State Medical Board 2006-2012

PROFESSIONAL ORGANIZATIONS:

American Society of Retina Specialists, Member
American Academy of Ophthalmology, Fellow
European Society of Retina Specialists, Member
New Orleans Academy of Ophthalmology, Member
Arkansas Medical Society, Member

HONORS & AWARDS

American Heart Association Research Grant, Louisiana Tech University
Frank Bogard Memorial Scholarship, Louisiana Tech University
Biomedical Engineering Best Prototype Award Senior Design Project,
Louisiana Tech University
Phi Kappa Phi Honor Society, Louisiana Tech University
Tau Beta Pi National Engineering Honor Society, Louisiana Tech University
Alpha Eta Mu Beta, Biomedical Engineering Honor Society, 
Louisiana Tech University
Alpha Epsilon Delta Premedical Honor Society, Louisiana Tech University
Commendation Letter on Outstanding Performance- Internal Medicine Clerkship, 
Louisiana State University Health Sciences Center.
Outstanding Resident Research Presentation Award,
Tulane Ophthalmology C.S. O’Brien Professorship Lecture Series 2006.

INVESTIGATIONAL STUDIES

The Effects of Thermal Injury and Duration of Thermal Exposure on Osteonecrosis in the Rat Model- undergraduate research project – 1998 Louisiana Tech University

CNTF2/Geographic Atrophy: A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF) in Participants with Visual Acuity Impairment Associated with Atrophic Macular Degeneration, Sub- Investigator 2007-2008

CNTF 3/ Late-Stage Retinitis Pigmentosa: A Phase II/III Study of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNFT) for participants with Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome, Sub- Investigator Sept 2007 – June 2008

CNTF 4/ Early-stage Retinitis Pigmentosa:  A Phase II/III Study of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNFT) for participants with Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome, Sub- Investigator Sept 2007 – June 2008

LX211 as Therapy in Subjects with Clinically Quiescent Sight Threatening, Non-Infectious Intermediate-, Anterior and Intermediate, Posterior-or Pan-Uveitis, A Double – Masked Placebo-Controlled, Multi-Center, Parallel Group, Dose-ranging Study to Assess the Efficacy and Safety of Sub- Investigator Sept 2007 – June 2008

LX211 as Therapy in Subjects with Active Sight-Threatening, Non-Infectious Anterior Uveitis, A Double – Masked Placebo-Controlled, Multi-Center, Parallel Group, Dose-ranging Study to Assess the Efficacy and Safety. Sub- Investigator Sept 2007 – June 2008

Genentech, GX29633 (Proxima A) A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration, Sub-Investigator

Genentech, GX29455 (Exposure) A Phase II, Multicenter, Randomized, Single-Masked, Sham Injection-Controlled Exposure-Response Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Patients with Geographic Atrophy, Sub-Investigator

Allergan 150998-001 (Sequoia) Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration, Sub-Investigator

Roche/Genentech, GR40398 (Rhine) A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of RO6867461 in Patients with Diabetic Macular Edema, Sub-Investigator

Kanghong Biotech, KBH-1802 (Panda-2) A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-Related Macular Degeneration (AMD), Sub-Investigator

Kodiak, KSI-CL-102 (DAZZLE) A Phase 2, Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-Center Study to Investigate the Efficacy and Safety of Repeated Intravitreal Administration of KSI-301 in Subjects with Neovascular (Wet) Age-related Macular Degeneration, Sub-Investigator

PUBLICATIONS:

Esfahani MR, Kazi AA, Peyman GA, DellaCroce JT, Aydin E:  Intravitreal toxicity of garenoxacin.  Retina. 2006 Feb; 26(2): 182-6.

Peyman GA, DellaCroce JT, Ebrahim SA:  Removal of Submacular Exudates in a Patient with Coats’ Disease: Case Report.  Retina. 2006 Sep; 26(7):836-9.

Kivilcim M, Peyman GA, Kazi AA, DellaCroce J, Ghobrial RN, Monzano R:  Intravitreal toxicity of high dose etanercept.
J Ocul Pharmacol Ther. 2007 Feb;23(1):57-62.

DellaCroce, J.T.  Surgical removal of submacular exudates in Coats’ disease. In:  Peyman, G.A., Meffert, S.A. and Conway, M.D. (eds.)  Vitreoretinal surgical techniques 2007.  2nd ed. London:  Informa, 2007 pp. 748-749.

Jermak CM, DellaCroce JT, Heffez J, Peyman GA: Triamcinolone acetonide in ocular therapeutics.  Survey of Ophthalmology. 2007 Sep-Oct; 52(5): 503-22.

Peyman GA, Kivilcim M, Morales AM, DellaCroce JT, Conway MD:  Inhibition of corneal angiogenesis by ascorbic acid in the rat model.  Graefes Arch Clin Exp Ophthalmol.  2007 Oct; 245(10): 1461-7.

Bernstein PS, DellaCroce JT:  Diagnostic & therapeutic challenges.  Tamoxifen toxicity.  Retina. 2007 Sep; 27(7): 982-8.

DellaCroce J, Laursen J, Ayyala RS:  Serous retinal detachment following glaucoma surgery.  Ophthalmic Surg Lasers Imaging. 2007 Nov-Dec; 38(6): 503-4.

DellaCroce JT, Vitale A: Hypertension and the eye. Current Opinion in Ophthalmology. 19(6):493-498, November 2008

DellaCroce JT, Bernstein PS, Moshirfar M, Espandar L:  American Academy of Ophthalmology, Focal Points:  Post-Operative Endophthalmitis.  Module #1, 2012

PROFESSIONAL PRESENTATIONS:

“Bacterial Keratitis Associated with Soft Contact Lens Wear” 
Tulane University Health Sciences Center 
Department of Ophthalmology
Grand Rounds 12/2003

“Management of Floppy Eyelid Syndrome and its Complications” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 01/2004

“Optic Disc Drusen” 
Tulane University Health Sciences Center Department of Ophthalmology 
Grand Rounds 01/2004

“Excision of an Orbital Conjunctival Inclusion Cyst- A Case Report” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 02/2004

“Differential Diagnosis and Treatment of Benign Eyelid Lesions” 
Tulane University Health Sciences Center 
Department of Ophthalmology
Grand Rounds 03/2004

“A Case of Shaken Baby Syndrome” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 03/2004

“A Review of Ocular Histoplasmosis Syndrome” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 04/2004

“Therapeutic Options in the Keratoconus Patient” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 05/2004

“Orbital Parosteal Osteosarcoma” 
American Academy of Ophthalmic Pathologists Annual Meeting 
New Orleans, LA 10/2004

“Surgical Intervention for Post-Traumatic V-Pattern Esotropia with Excyclotorsion” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 11/2004

“Pseudoxanthoma Elasticum” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Fluorescein Angiogram Conference 12/2004

“Stargardt Disease” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Fluorescein Angiogram Conference 12/2004

“Traumatic Hyphema with Increased Intraocular Pressure in a Patient with Sickle Cell Trait” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 01/2005

“Capillary Hemangioma and its Management- A Case Report” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 02/2005

 “Intravitreal Toxicity of Garenoxacin” 
Association for Research and Vision and Ophthalmology (ARVO)
Annual Meeting Poster Presentation 05/2005

“Toxoplasma Retinitis” 
Tulane University Health Sciences Center 
Department of Ophthalmology 
Grand Rounds 06/2005

“Pars Planitis and Toxoplasma Retinochoroiditis” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 08/2006

“Removal of submacular exudates in patient with Coats’ Disease” 
University of Utah 
Moran Eye Center 
Clinical Faculty Day 09/2006

“Melanocytoma” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 10/2006

“Retinal Angiomatous Proliferation”
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 10/2006

“West Nile Virus Retinitis” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 10/2006

“White Dot Syndromes” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 11/2006

“Review of Endophthalmitis” 
University of Utah 
Moran Eye Center 
Grand Rounds 01/2007

“Macular Hole and Choroidal Neovascularization” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 01/2007

“Retinoschisis” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 02/2007

“Parafoveal Retinal Telangiectasis”
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 05/2007

Toxocariasis” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 05/2007

“Fluorescein Angiography” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 08/2007

“Inhibition of Corneal Angiogenesis by Ascorbic Acid” 
University of Utah 
Moran Eye Center 
Clinical Faculty Day 09/2007

“P.acnes Endophthalmitis Masquerading as Chronic Uveitis” 
University of Utah 
Moran Eye Center 
Grand Rounds 10/2007

“Optic Disc Drusen with Adjacent CNV” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 01/2008

“Multifocal Choroiditis and Panuveitis with associated Choroidal Neovascular Membrane” 
University of Utah 
Moran Eye Center 
Fluorescein Angiogram Conference 02/2008

“Relentless Placoid Chorioretinitis” 
Salt Lake City Retina Fluorescein Conference 02/2008

“Endophthalmitis”
Tulane University Health Sciences Center
Department of Ophthalmology 
Basic Science Course 08/2009

“Macular Degeneration”
Tulane University Health Sciences Center
Department of Ophthalmology 
Basic Science Course 08/2009

POSTGRADUATE COURSES:

Ophthalmic Lasers and Safety Certification
Tulane University Health Sciences Center 2005

Assessing Predictive Indicators in DME 
Advisory Board Meeting 
Allergan 
New York, NY 2018

Continued Unmet Clinical Needs of DME Patients
Retina Advisory Boards
Allergan
Dallas, TX 2019

Scroll to Top